@article{TLCR23668,
author = {Surein Arulananda and Paul Mitchell},
title = {Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy—fortune favours the bold},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 4},
year = {2018},
keywords = {},
abstract = {Around a third of non-small cell lung cancer (NSCLC) patients present with stage III disease. The majority are not suitable for surgery and until very recently, the standard-of-care for unresectable, good performance status patients with stage III disease has been platinum-doublet chemotherapy with high dose radiotherapy (RT), with no additional treatment.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/23668}
}